Home › Non-Muscle Invasive Bladder Cancer
Pag-aaral pangklinika para sa Non-Muscle Invasive Bladder Cancer na nagre-recruit sa U.S.
33 pag-aaral para sa Non-Muscle Invasive Bladder Cancer ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- New York City, NY10 pag-aaral
- Columbus, OH10 pag-aaral
- Dallas, TX10 pag-aaral
- Edison, NJ9 pag-aaral
- Myrtle Beach, SC9 pag-aaral
- Syracuse, NY8 pag-aaral
- Nashville, TN8 pag-aaral
- Baltimore, MD8 pag-aaral
- Philadelphia, PA7 pag-aaral
- Birmingham, AL7 pag-aaral
- Houston, TX7 pag-aaral
- Indianapolis, IN7 pag-aaral
- Atlanta, GA7 pag-aaral
- Austin, TX6 pag-aaral
- Los Angeles, CA6 pag-aaral
- Boston, MA6 pag-aaral
- Little Rock, AR6 pag-aaral
- San Antonio, TX6 pag-aaral
- St. Louis, MO6 pag-aaral
- Chicago, IL6 pag-aaral
- Bakersfield, CA5 pag-aaral
- Memphis, TN5 pag-aaral
- Cicero, IL5 pag-aaral
- Tampa, FL5 pag-aaral
- Durham, NC5 pag-aaral
- Staten Island, NY4 pag-aaral
- Greenburgh, NY4 pag-aaral
- East Norwalk, CT4 pag-aaral
- Queens, NY4 pag-aaral
- Seattle, WA4 pag-aaral
- Jacksonville, FL4 pag-aaral
- Pittsburgh, PA4 pag-aaral
- Lakewood, CO4 pag-aaral
- Kansas City, KS4 pag-aaral
- Washington, DC4 pag-aaral
- New Rochelle, NY3 pag-aaral
- Lafayette, LA3 pag-aaral
- Cincinnati, OH3 pag-aaral
- Phoenix, AZ3 pag-aaral
- Arlington, TX3 pag-aaral
Ayos sa estado
- Alabama7 pag-aaral
- Arizona9 pag-aaral
- Arkansas6 pag-aaral
- California15 pag-aaral
- Colorado5 pag-aaral
- District of Columbia4 pag-aaral
- Florida15 pag-aaral
- Georgia7 pag-aaral
- Illinois11 pag-aaral
- Indiana8 pag-aaral
- Iowa3 pag-aaral
- Kansas4 pag-aaral
- Louisiana5 pag-aaral
- Maryland8 pag-aaral
- Massachusetts10 pag-aaral
- Michigan7 pag-aaral
- Minnesota4 pag-aaral
- Missouri7 pag-aaral
- New Jersey9 pag-aaral
- New York16 pag-aaral
- North Carolina6 pag-aaral
- Ohio13 pag-aaral
- Oregon3 pag-aaral
- Pennsylvania9 pag-aaral
- South Carolina12 pag-aaral
- Tennessee10 pag-aaral
- Texas15 pag-aaral
- Virginia6 pag-aaral
- Washington5 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07000084A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06833073Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT06995677A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06919965A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07206225A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07309445A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06733363Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT05796375A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT06503614Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07144319A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT06637423Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT05951179Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT05825950Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT07480356A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)
Nagre-recruitPhase 3
Edad 21 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT06929286FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT05614739A Phase I Intravesical PPM Therapy for NMIBC
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT05519241Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 14, 2026 · NCT05126472Sample Collection for Ongoing Research and Product Evaluation Study - Non-muscle Invasive Bladder Cancer (SCORE-NMIBC)
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 13, 2026 · NCT07763197LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT04752722Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT07225127Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT07673016A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update May 27, 2026 · NCT05710848Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC
Nagre-recruitPhase 2
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Abr 17, 2026 · NCT07322263In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 30, 2026 · NCT06704191Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.